solid organ transplant


Also found in: Acronyms.

solid organ transplant

Immunology A transplanted solid organ–eg, heart, liver, kidney, as contrasted to 'liquid' transplanted tissues–eg, BM, pancreatic islets. See Transplant, Transplantation.
References in periodicals archive ?
Spatial distribution of solid organ transplant recipients in the southwest area of Madrid, Spain, in relation to park that was focus of visceral leishmaniasis (VL) outbreak, January 1,2005-January 1,2013.
Hospitals A and B are no longer using negative-pressure rooms to house solid organ transplant patients who are without a clinical indication.
Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients," American Journal of Transplantation, vol.
5 Rhodococcus was first described in humans in 1967 and is usually seen in immunocompromised hosts such as HIV-infected patients, solid organ transplant recipients, and in those with alcoholism, malignancies, diabetes mellitus and chronic renal failure.
CMVhyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.
Despite these limitations, this study provides important information for groups working with solid organ transplants.
In a recent observational study, the Minnesota group reported on 15 solid organ transplant recipients, mean age 57 years, with recurrent NMSCs who were placed on low-dose capecitabine for the off-label purpose of preventing further NMSCs.
Graft-vs-host disease after solid organ transplant.
Simon Bramell, a consultant liver transplant surgeon at the Queen Elizabeth Hospital in Edgbaston - the largest solid organ transplant centre in Europe - spoke out as the Chief Medical Officer Sir Liam Donaldson claimed the answer was to treat all people as donors.
The new Devens manufacturing facility is expected to support increased production capacity for commercially available biologic compounds, such as Orencia (abatacept), and help meet future production needs of biologic compounds currently in development, including the company's investigational treatments for solid organ transplant rejection and certain types of cancers.
The second half of the text covers applications in more detail and offers chapters on quantitative analyses of DNA methylation, mitochondrial DNA analysis, real-time immuno-PCR, clinical microbiology and virology, solid organ transplant modeling,real-time-PCR applications in hematology, and prenatal diagnosis of monogenic disease caused by single nucleotide changes.
Regimens that protect against bacterial, viral, and yeast infections are widely used for patients undergoing chemotherapy to prepare for bone marrow or stem cell transplantation, to prevent rejection of a solid organ transplant, to treat hematologic malignancy, or to control graft vs.